METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, olomorasib and pembrolizumab, as a first treatment for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and a PD-L1 score between 1% and 49%. The main goal is to see how long patients live without t…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
Disease control Not yet recruitingThis study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few resistant spots in metastatic lung cancer patients who are already on targeted therapy (TKI). About 60 adults with EGFR or ALK mutations will receive radiation to those spots, and do…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple mineral improve lung cancer treatment?
Disease control Not yet recruitingThis study tests whether adding magnesium to standard chemo-immunotherapy helps people with advanced non-small cell lung cancer. About 230 participants will receive either magnesium or a placebo, as both tablets and infusions. Neither patients nor doctors know who gets what. The …
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC